Back
Day Range
$34.85
$38.91
52-Week Range
$6.42
$39.15
Volume
959,958
50D / 200D Avg
$32.17
/
$19.01
Prev Close
$37.15
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -16.4 | 0.4 |
| P/B | 7.6 | 2.9 |
| ROE % | -39.8 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Debt/Equity of 0.02 — conservative balance sheet
Negative free cash flow of -95.28M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-39.83%
ROIC-37.58%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.02
Current Ratio14.67
Interest Coverage0.00
Valuation
P/E Ratio
-16.35
P/B Ratio7.57
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -119.95M |
| ROE | -39.83% | ROA | -42.44% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -95.28M |
| ROIC | -37.58% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 14.67 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -16.35 | P/B Ratio | 7.57 |
| P/S Ratio | N/A | PEG Ratio | -0.39 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.96B | Enterprise Value | 1.89B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -119.95M | -86.48M | -69.13M | -55.33M | -26.29M |
| EPS (Diluted) | -2.01 | -1.51 | -1.62 | -1.23 | -0.63 |
| Gross Profit | -546,000.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -132.76M | -104.18M | -79.95M | -58.93M | -26.29M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 282.61M | 363.56M | 225.86M | 266.18M | 306.70M |
| Total Liabilities | 23.43M | 20.41M | 21.60M | 8.35M | 4.96M |
| Shareholders' Equity | 259.18M | 343.15M | 204.26M | 257.83M | 301.74M |
| Total Debt | 5.81M | 6.22M | 6.50M | 2.62M | 1.18M |
| Cash & Equivalents | 77.39M | 91.97M | 58.01M | 251.21M | 302.18M |
| Current Assets | 265.45M | 347.46M | 211.67M | 257.29M | 304.06M |
| Current Liabilities | 18.09M | 14.59M | 15.33M | 5.70M | 3.62M |